Qiyu Biotech
Shanghai
About Qiyu Biotech
Qi Xiangdong, founder of Qiyu Bio, said: “Innovation is the starting and future of Qiyu Bio, and it is the core driving force of enterprise development. Qiyu Bio will use the first-class antibody technology platform to build superior biopharmaceutical pipelines and explore the field of biotherapy. A big breakthrough. With the development and improvement of the company, Qiyu will have core competitiveness in more fields.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $31.4M
- Funding stage: Early Stage Venture
- Last round: Series B (Dec 2021)
Industries & Categories
Biotechnology, Health Care, Medical
Canonical: https://fsome.com/organization/qiyu-biotech-129506 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.